Favorite

UAMS researchers receive cancer grants 

Press Release

UAMS Medical Center

UAMS Researchers Receive National Cancer Institute
Grants Totaling More Than $540,000

LITTLE ROCK — Two researchers at the University of Arkansas for Medical Sciences (UAMS) have received research grants for pancreatic cancer and multiple myeloma, a cancer of the bone marrow.

Randy Haun, associate professor of pathology at the UAMS Arkansas Cancer Research Center (ACRC), was granted $293,048 from the National Cancer Institute for his project titled “Early Detection of Pancreatic Cancer.”

“Currently, there are no reliable screening tests available for early diagnosis of pancreatic cancer,” Haun said. “There is a desperate need for better methods of detection of this disease at an early, operable stage.”

Haun’s project will use state-of-the-art processes to identify proteins in serum that may be used for early detection of pancreatic cancer.

The project is in collaboration with Ralph Broadwater, M.D., associate professor of surgery, chief of surgical oncology and vice chairman of clinical affairs at UAMS; Cheryl Lichti, Ph.D., research assistant professor and co-director of the ACRC Proteomics Core Facility; Eric Siegel, biostatistics research associate in the UAMS College of Public Health; and Diane Simeone, M.D., surgical director of the Multidisciplinary Pancreatic Cancer Clinic and associate professor of surgery at the University of Michigan.

Joshua Epstein, professor of medicine in the UAMS Myeloma Institute for Research and Therapy, has received a grant of $255,050 from the National Cancer Institute to study osteoblasts and their mesenchymal progenitors in myeloma. The grant will fund the study of the relationship between myeloma tumor cells and the cells in bone marrow responsible for making new bone.

“Even when multiple myeloma patients are in complete remission, the damage that the disease causes to their bones is not repaired. In other forms of cancer, bone damage is repaired when the cancer is eliminated,” Epstein said. He will examine ways to use mesenchymal stem cells to repair bone damage as well as to control the spread of multiple myeloma.

Favorite

From the ArkTimes store

Speaking of Medical News

Comments

Subscribe to this thread:

Add a comment

More by Crystal Wallis

Most Shared

Latest in Medical Community

  • UAMS earns 10-year reaccreditation

    The University of Arkansas for Medical Sciences (UAMS) recently learned that it has been reaccredited another 10 years by the Higher Learning Commission of the North Central Association of Colleges and Schools.
    • Oct 16, 2007
  • UAMS performs 7,000th stem-cell transplant

    The internationally known treatment program for multiple myeloma at the University of Arkansas for Medical Sciences (UAMS) reached another milestone today (Oct. 10) as Jeffrey Zwerin of California received the 7,000th stem-cell transplant procedure perfor
    • Oct 10, 2007
  • Richard Morrison receives endowed chair

    Richard P. Morrison, M.D., today became the inaugural recipient of the Chair in Sciences Basic to Medicine at the University of Arkansas for Medical Sciences (UAMS).
    • Oct 9, 2007
  • More »

Event Calendar

« »

December

S M T W T F S
  1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31  

Most Viewed

Most Recent Comments

  • Re: Banker signs on for Rx accounts

    • Pain relief, sleeping better, people reducing AND even eliminating opiate use. Have yet to find…

    • on December 14, 2017
  • Re: Banker signs on for Rx accounts

    • So "outside of those four states, consumers must put their trust in the manufacturer"? OR…

    • on December 14, 2017
  • Re: The class of 2016

    • Government by the People means we have to be active citizens. I am greatful for…

    • on December 14, 2017
 

© 2017 Arkansas Times | 201 East Markham, Suite 200, Little Rock, AR 72201
Powered by Foundation